Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies

Respiration

Volumn 94, Issue 3, 2017, Pages 299-311

  Almirall, Jordi ^a,b   Serra Prat, Mateu ^c,d   Bolíbar, Ignasi ^a,e   Balasso, Valentina ^f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Research Unit   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Adults; Community acquired pneumonia; Observational studies; Risk factors; Systematic review

Indexed keywords

ACETYLCYSTEINE; AMINOPHYLLINE; ANTACID AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; INFLUENZA VACCINE; IRON; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PNEUMOCOCCUS VACCINE; STEROID; VITAMIN; XANTHINE DERIVATIVE;

ADULT; AGE; ALCOHOL CONSUMPTION; ASTHMA; CASE CONTROL STUDY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSPHAGIA; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; FUNCTIONAL DISEASE; GENDER; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INHALATIONAL DRUG ADMINISTRATION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MALIGNANT NEOPLASM; MALNUTRITION; MORTALITY; NEWCASTLE-OTTAWA SCALE; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; RADIODIAGNOSIS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SMOKING; SYSTEMATIC REVIEW; TOOTH DISEASE; COMMUNITY ACQUIRED INFECTION; PNEUMONIA;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PNEUMONIA; RISK FACTORS;

EID: 85026457452     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000479089     Document Type: Review

References (51)

1. Ewig S, Torres A: Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J 2011; 38: 253-260.
2. Almirall J, Bolibar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agusti M, Ayuso P, Estela A, Torres A: New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J 2008; 31: 1274-1284.
3. Kohlhammer Y, Schwartz M, Raspe H, Schafer T: Risk factors for community acquired pneumonia (CAP).A systematic review (in German). Dtsch Med Wochenschr 2005; 130: 381-386.
4. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 15: 264-269.
5. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. 2014. http: //www. ohri. ca/programs/clinical-epidemiology/oxford. asp (accessed December 14, 2015).
6. Almirall J, Bolibar I, Balanzo X, Gonzalez CA: Risk factors for community-acquired pneumonia in adults: a population-based casecontrol study. Eur Respir J 1999; 13: 349-355.
7. Almirall J, Serra-Prat M, Bolibar I, Palomera E, Roig J, Boixeda R, Bartolome M, de la Torre M, Parra O, Torres A: Professions and working conditions associated with communityacquired pneumonia (in English, Spanish). Arch Bronconeumol 2015; 51: 627-631.
8. Almirall J, Bolibar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agusti M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries: Inhaled drugs as risk factors for community-acquired pneumonia. Eur Respir J 2010; 36: 1080-1087.
9. Almirall J, Rofes L, Serra-Prat M, Icart R, Palomera E, Arreola V, Clave P: Oropharyngeal dysphagia is a risk factor for communityacquired pneumonia in the elderly. Eur Respir J 2013; 41: 923-928.
10. Alperovich M, Neuman MI, Willett WC, Curhan GC: Fatty acid intake and the risk of community-acquired pneumonia in US women. Nutrition 2007; 23: 196-202.
11. Neuman MI, Willett WC, Curhan GC: Vitamin and micronutrient intake and the risk of community-acquired pneumonia in US women. Am J Med 2007; 120: 330-336.
12. Neuman MI, Willett WC, Curhan GC: Physical activity and the risk of community-acquired pneumonia in US women. Am J Med 2010; 123: 281. e7-281. e11.
13. Atsumi E, Yara S, Higa F, Hirata T, Haranaga S, Tateyama M, Fujita J: Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia. Intern Med 2009; 48: 959-965.
14. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW: A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160: 3082-3088.
15. Dang TT, Eurich DT, Weir DL, Marrie TJ, Majumdar SR: Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up. Clin Infect Dis 2014; 59: 74-80.
16. de Melo Neto JP, Melo MS, Dos Santos-Pereira SA, Martinez EF, Okajima LS, Saba-Chujfi E: Periodontal infections and community-acquired pneumonia: a case-control study. Eur J Clin Microbiol Infect Dis 2013; 32: 27-32.
17. Doshi SM, Rueda AM, Corrales-Medina VF, Musher DM: Anemia and community-acquired pneumococcal pneumonia. Infection 2011; 39: 379-383.
18. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR: Recurrent communityacquired pneumonia in patients starting acidsuppressing drugs. Am J Med 2010; 123: 47-53.
19. Eurich DT, Lee C, Marrie TJ, Majumdar SR: Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested casecontrol study. Clin Infect Dis 2013; 57: 1138-1144.
20. Farr BM, Bartlett CLR, Wadsworth J, Miller DL: Risk factors for community-acquired pneumonia diagnosed upon hospital admission. Respir Med 2000; 94: 954-963.
21. Farr BM, Woodhead MA, Macfarlane JT, Bartlett CL, McCraken JS, Wadsworth J, Miller DL: Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med 2000; 94: 422-427.
22. Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A: High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995; 155: 1649-1654.
23. Gau JT, Acharya U, Khan S, Heh V, Mody L, Kao TC: Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr 2010; 10: 45.
24. Jackson LA, Neuzil KM, Yu, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW: Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-1755.
25. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA: The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 2004; 39: 1642-1650.
26. Jovanovich AJ, Ginde AA, Holmen J, Jablonski K, Allyn RL, Kendrick J, Chonchol M: Vitamin D level and risk of community-acquired pneumonia and sepsis. Nutrients 2014; 6: 2196-2205.
27. Juthani-Mehta M, De Rekeneire N, Allore H, Chen S, O'Leary JR, Bauer DC, Harris TB, Newman AB, Yende S, Weyant RJ, Kritchevsky S, Quagliarello V; Health ABC Study: Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc 2013; 61: 1111-1118.
28. Kang DR, Kim YK, Park MS, Kim YS, Ko DH, Kim C: Low levels of serum cholesterol and albumin and the risk of community-acquired pneumonia in young soldiers. Int J Tuberc Lung Dis 2008; 12: 26-32.
29. Koivula I, Sten M, Makela PH: Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-320.
30. Loeb M, Neupane B, Walter SD, Hanning R, Carusone SC, Lewis D, Krueger P, Simor AE, Nicolle L, Marrie TJ: Environmental risk factors for community-acquired pneumonia hospitalization in older adults. J Am Geriatr Soc 2009; 57: 1036-1040.
31. Meijvis SC, Cornips MC, Voorn GP, Souverein PC, Endeman H, Biesma DH, Leufkens HG, van de Garde EM: Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. Eur Respir J 2011; 38: 1165-1172.
32. Merchant AT, Curhan G, Bendich A, Singh VN, Willett WC, Fawzi WW: Vitamin intake is not associated with community-acquired pneumonia in US men. J Nutr 2004; 134: 439-444.
33. Merchant AT, Curhan GC, Rimm EB, Willett WC, Fawzi WW: Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr 2005; 82: 668-674.
34. Neupane B, Jerrett M, Burnett RT, Marrie T, Arain A, Loeb M: Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults. Am J Respir Crit Care Med 2010; 181: 47-53.
35. Palmer KT, Poole J, Ayres JG, Mann J, Burge PS, Coggon D: Exposure to metal fume and infectious pneumonia. Am J Epidemiol 2003; 157: 227-233.
36. Paul KJ, Walker RL, Dublin S: Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study. J Am Geriatr Soc 2015; 63: 476-485.
37. Piednoir E, Novella JL, Bureau-Chalot F, Jolly D, Blanchard F: Risk factors for community acquired pneumonia in persons older than 80 years. (Article in French). Rev Geriatr 2003; 28: 789-798.
38. Riquelme R, Torres A, El-Ebiary M, de la Bellacasa JP, Estruch R, Mensa J, Fernandez-Sola J, Hernandez C, Rodriguez-Roisin R: Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 154: 1450-1455.
39. Vila-Corcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodriguez T, Gomez A: Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J 2005; 26: 1086-1091.
40. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F; EPIVAC Study Group: Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009; 103: 309-316.
41. Huss A, Scott P, Stuck AE, Trotter C, Egger M: Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180: 48-58.
42. Schiffner-Rohe J, Witt A, Hemmerling J, von Eiff C, Leverkus FW: Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk-a systematic review and meta-analysis. PLoS One 2016; 11: e0146338.
43. Diao WQ, Shen N, Yu PX, Liu BB, He B: Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials. Vaccine 2016; 34: 1496-1503.
44. Kraicer-Melamed H, O'Donnell S, Quach C: The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: a systematic review and meta-analysis. Vaccine 2016; 34: 1540-1550.
45. Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, Patton M, McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW, Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE: Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372: 1114-1125.
46. Osterholm MT, Kelley NS, Sommer A, Belongia EA: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 36-44.
47. Gubbins PO, Li C: The influence of influenza and pneumococcal vaccines on communityacquired pneumonia (CAP) outcomes among elderly patients. Curr Infect Dis Rep 2015; 17: 49.
48. Jenkins TC, Sakai J, Knepper BC, Swartwood CJ, Haukoos JS, Long JA, Price CS, Burman WJ: Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia. Acad Emerg Med 2012; 19: 703-706.
49. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB: Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955-1960.
50. Filion KB, Chateau D, Targownik LE, Gershon A, Durand M, Tamim H, Teare GF, Ravani P, Ernst P, Dormuth CR; CNODES Investigators: Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut 2014; 63: 552-558.
51. Rodriguez F, Bolibar I, Serra-Prat M, Palomera E, Ballester MV, Almirall J; on behalf of the Community-Acquired Pneumonia in Catalan Countries (PACAP): Poor oral health as risk factor for community-acquired pneumonia. J Pulm Respir Med 2014; 4: 203.